Convergent Dental Reaches 2,000 Solea Dental Lasers Across North America

Convergent Dental Reaches 2,000 Solea Dental Lasers Across North America

Milestone Reflects Solea’s Impact on Elevating Patient Care and Practice Growth Waltham, MA (January 21, 2025) – Convergent Dental, the power behind the Solea^® All-Tissue Dental Laser, announces the installation of the 2,000th Solea laser. This significant milestone underscores the rapidly growing adoption of Solea among dental professionals across North America.

“Our 2,000th installation is a testament to the trust and enthusiasm the dental community has for Solea,” said Convergent Dental CEO, Robert L. Gershon. “From solo practitioners to dental service organizations (DSOs) to dental schools, dental professionals are embracing Solea to improve patient experience, clinical effectiveness, practice efficiency, and procedural expansion.”

Solea, the only 9.3-micron CO2 laser, has elevated the way dentists deliver care by enabling anesthesia-free, blood-free, and pain-free procedures in hard and soft tissue¹. Its versatility allows dentists to expand their treatment offerings, enhance clinical outcomes, and increase efficiency, including more same-day and multi-quadrant dentistry. Patients benefit from less discomfort and anxiety, fewer appointments, and an overall improved dental experience.

Convergent Dental remains committed to innovation and customer support, ensuring that every Solea dentist has access to the education, resources, and tools needed to succeed and maximize their laser's potential. "As we continue to drive the broad-based adoption of Solea, we are empowering dentists, practices, academic institutions, and patients to redefine the dental experience," added Gershon.

For more information about Solea, visit www.convergentdental.com/solea.

About Convergent Dental

Convergent Dental, Inc. (www.convergentdental.com) is a privately owned dental equipment and technology company. The Company's flagship product, Solea^®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists and patients can rely on.¹ Solea^® enables dentists to elevate their practices through improved efficiency, patient experience, clinical effectiveness, and procedural expansion.²

1. Based on report of 1000 procedures performed by Solea users. Documentation on file.
2. Based on 2022 Annual Survey of Solea users. Documentation on file.